Spero Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $153.5M
Liabilities Breakdown FY2020
Total Liabilities: $21.4M
Asset Breakdown
Total Assets: $153.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $85.2M | 55.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.7M | 1.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $66.6M | 43.4% |
Liabilities Breakdown
Total Liabilities: $21.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.2M | 5.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $20.3M | 94.6% |